Today, Time chose Johnson & Johnson for inclusion on its first-ever list of TIME100 Most Influential Companies. An extension of the publication’s annual TIME100 list of the world’s most influential people, the new list singles out 100 companies that are positively impacting the world.
To curate the international list, Time tapped industry experts, as well as its own editors and correspondents around the world, for nominations in every sector—from healthcare and entertainment to technology and transportation. The publication’s editors then evaluated the influence of each company not on the basis of size or scale, but with an eye on relevance, impact, innovation, leadership and success, among other key factors.
It’s factors like these that guide decision-making at Johnson & Johnson every day, and have been at the heart of the company since its founding in 1886.
“At a time where the stakes of good health have never been higher, this TIME100 Companies award spotlights the full impact of our work at Johnson & Johnson,” says Alex Gorsky, Johnson & Johnson’s Chairman and CEO. “From the deployment of our Janssen COVID-19 Vaccine to our continued, relentless commitment to innovation, I couldn’t be more proud of how we’re improving the lives of people all around the world.”
When COVID-19 hit, Johnson & Johnson was able to respond to the once-in-a-lifetime challenge by harnessing its capabilities, scientific expertise, global partnerships and experience helping fight pandemics for over a century.
When COVID-19 hit, Johnson & Johnson was able to respond to the once-in-a-lifetime challenge by harnessing its capabilities, scientific expertise, global partnerships and experience helping fight pandemics for over a century.
And Johnson & Johnson is equally focused on addressing a range of evolving needs of patients, consumers and healthcare providers. That includes a commitment to helping eradicate racial and social injustice as a public health threat by helping to eliminate health inequities for people of color; helping expand access to medicine for multidrug-resistant tuberculosis, a hard-to-treat form of the disease; working to make clinical trials more accessible to patients; and using the company’s innovative packaging and harnessing cutting-edge technologies to ensure that all of Johnson & Johnson Consumer Health brands will use 100% recyclable, reusable or compostable plastic packaging by the year 2025.
That ethos provides the foundation for Our Credo, the company’s guiding mission statement crafted by Robert Wood Johnson, a member of Johnson & Johnson’s founding family, in 1943. Our Credo compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.
Johnson & Johnson is proud to be recognized for the work we do by being included among the TIME100 Most Influential Companies.
